Page results
-
A summary of a twitter chat hosted by the Macmillan Support and Information Service on cancer-related fatigue with advice about to manage it.
-
The Department of Health and Social Care has published the National Cancer Plan for England. It sets out a bold, long-term approach to improving cancer outcomes, experience and equity over the next decade.
-
This page has been written to answer some common questions about Tofersen treatment for patients, as well as their caregivers and families.
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
This page has been written for parents and carers whose child is having a single fraction (one treatment) total body irradiation (TBI) for a benign (non-cancerous) blood disorder such as sickle cell anaemia, aplastic anaemia, thalassaemia, or some other condition.
-
This page has been written for children and young people and explains what deinfibulation is.
-
Information about percutaneous endoscopic interlaminar lumbar discectomy for patients with sciatica.
-
Endoscopic spinal surgery (ESS) is a type of minimally invasive spinal surgery (keyhole surgery). This page provides information about transforaminal endoscopic lumbar discectomy (PTELD).
File results
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0315 - Menopause Lead at the Trust